Papaveretum and scopolamine only product in parenteral dose form
|
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
Id782041008
StatusDefined
Has manufactured dose formSolution for injection
Has BoSSpapaveretum
Has concentration strength denominator unitmL
Has concentration strength numerator unitmg
Has precise active ingredientpapaveretum
Has BoSSScopolamine hydrobromide
Has concentration strength denominator unitmL
Has concentration strength numerator unitmcg
Has precise active ingredientScopolamine hydrobromide